Skip to main content
. 2022 Sep 29;12:1005571. doi: 10.3389/fonc.2022.1005571

Figure 3.

Figure 3

Kaplan-Meier overall survival curves of HCC patients receiving TACE therapy, stratified by our newly proposed scoring system with cutoff set at 3. HCC, hepatocellular carcinoma; TACE, transarterial chemoembolization.